HY-140499-100mg
|
MedChemexpress LLC
|
m-PEG9-acid [CAS 2576495-35-5]
|
|
Cancer-programmed cell death
|
|
HY-119464-10mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
HY-119464-100mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
HY-119464-25mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
HY-119464-5mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
HY-119464-50mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
HY-W011916-5mg
|
MedChemexpress LLC
|
Mu ramic acid [CAS 1114-41-6]
|
|
COVID-19-immunoregulation
|
|
HY-B0199-1g
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-100mg
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-200mg
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-5g
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-1mL
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-137301-1mg
|
MedChemexpress LLC
|
Mycophenolic acid glucuronide [CAS 31528-44-6]
|
|
Cancer-programmed cell death
|
|
HY-137301-10mg
|
MedChemexpress LLC
|
Mycophenolic acid glucuronide [CAS 31528-44-6]
|
|
Cancer-programmed cell death
|
|
HY-137301-25mg
|
MedChemexpress LLC
|
Mycophenolic acid glucuronide [CAS 31528-44-6]
|
|
Cancer-programmed cell death
|
|
HY-137301-5mg
|
MedChemexpress LLC
|
Mycophenolic acid glucuronide [CAS 31528-44-6]
|
|
Cancer-programmed cell death
|
|
HY-137301-1mL
|
MedChemexpress LLC
|
Mycophenolic acid glucuronide [CAS 31528-44-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-140521-100mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
HY-140521-50mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
HY-130695-100mg
|
MedChemexpress LLC
|
N-(Amino-PEG5)-N-bis(PEG4-acid) [CAS 2093152-86-2]
|
|
Cancer-programmed cell death
|
|
HY-130695-25mg
|
MedChemexpress LLC
|
N-(Amino-PEG5)-N-bis(PEG4-acid) [CAS 2093152-86-2]
|
|
Cancer-programmed cell death
|
|
HY-130695-50mg
|
MedChemexpress LLC
|
N-(Amino-PEG5)-N-bis(PEG4-acid) [CAS 2093152-86-2]
|
|
Cancer-programmed cell death
|
|
HY-140525-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG4-acid [CAS 2093153-82-1]
|
|
Cancer-programmed cell death
|
|
HY-140525-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG4-acid [CAS 2093153-82-1]
|
|
Cancer-programmed cell death
|
|
HY-140247-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG3)-N-(PEG2-amine)-PEG3-acid [CAS 2183440-70-0]
|
|
Cancer-programmed cell death
|
|